Cue Biopharma (CUE) Update / Briefing Transcript

Cue Biopharma (CUE) Update / Briefing May 15, 2025 11:00 AM ET Speaker0 Good morning, and welcome to the CUE Biopharma's novel biologics portfolio. At this time, all attendees are in a listen only mode. Today's call will focus on a review of CUE's novel biologics development platform for immobilizing the immune system. Joining me on today's call is CUE Biopharma's Chief Executive Officer, Dan Pusari two recognized T cell researchers, Doctor. Richard DePalo and Doctor. Andy Cope and members of CUE Management ...